Skip to main content

Starling Oncology, Inc.

STLNW
Exchange
Nasdaq
Industry
Services-Offices & Clinics of Doctors of Medicine
SEC CIK
0001799191

In the last 90 days, Starling Oncology, Inc. insiders filed 3 open-market purchases and 2 sales; 12 institutions reported holding it in 13F filings for Q2 2026, worth $163.5K in total; no superinvestor holds it.

Other share classesDFPHSTLN

13F holders, Q3 2024

Institutional positions in Starling Oncology, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
15
−3 vs. Q2 2024
Shares held
2.60M
−1.65M (−38.9%) vs. Q2 2024
Total value
$52.0K
−$56.0K (−51.9%) vs. Q2 2024
New holders
0
0 more added
Sold out
3
5 more reduced

Compare with Q2 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting STLNW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2024: 15 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 22 institutionsQ1 2022: 14 institutionsQ2 2022: 13 institutionsQ3 2022: 14 institutionsQ4 2022: 14 institutionsQ1 2023: 17 institutionsQ2 2023: 15 institutionsQ3 2023: 15 institutionsQ4 2023: 16 institutionsQ1 2024: 15 institutionsQ2 2024: 18 institutionsQ3 2024: 15 institutionsQ4 2024: 14 institutionsQ1 2025: 11 institutionsQ2 2025: 11 institutionsQ3 2025: 12 institutionsQ4 2025: 11 institutionsQ1 2026: 11 institutionsQ2 2026: 12 institutions
Value heldQ3 2024: $52.0K
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $2.56MQ1 2022: $3.90MQ2 2022: $1.61MQ3 2022: $1.78MQ4 2022: $346.4KQ1 2023: $232.3KQ2 2023: $132.4KQ3 2023: $406.9KQ4 2023: $806.9KQ1 2024: $827.5KQ2 2024: $108.0KQ3 2024: $52.0KQ4 2024: $19.0KQ1 2025: $94.9KQ2 2025: $195.4KQ3 2025: $469.0KQ4 2025: $465.1KQ1 2026: $172.4KQ2 2026: $163.5K
Institutions holding STLNW and their total value by quarter
QuarterHoldersValue
Q2 202612$163.5K
Q1 202611$172.4K
Q4 202511$465.1K
Q3 202512$469.0K
Q2 202511$195.4K
Q1 202511$94.9K
Q4 202414$19.0K
Q3 202415$52.0K
Q2 202418$108.0K
Q1 202415$827.5K
Q4 202316$806.9K
Q3 202315$406.9K
Q2 202315$132.4K
Q1 202317$232.3K
Q4 202214$346.4K
Q3 202214$1.78M
Q2 202213$1.61M
Q1 202214$3.90M
Q4 202122$2.56M
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q3 2024

Shares, value and share of portfolio for each institution holding Starling Oncology, Inc.; share changes are against Q2 2024.

Institutions holding STLNW in Q3 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Deerfield Management Company, L.P. (Series C)1,250,000$25.0K0.00%00.0%Unchanged
Walleye Capital LLC393,545$7.87K0.00%00.0%Unchanged
Davidson Kempner Capital Management LP318,710$6.37K0.00%00.0%Unchanged
FreeGulliver LLC193,101$3.86K0.00%00.0%Unchanged
Man Group plc88,824$1.78K0.00%00.0%Unchanged
Healthcare of Ontario Pension Plan Trust Fund87,500$1.75K0.00%00.0%Unchanged
Cowen and Company, LLC86,726$1.73K0.00%−400−0.5%Reduced
Wolverine Asset Management LLC74,720$1.49K0.00%00.0%Unchanged
Two Sigma Investments, LP30,000$6000.00%00.0%Unchanged
Tenor Capital Management Co., L.P.25,000$5000.00%00.0%Unchanged
Alpine Global Management, LLC25,024$5000.00%00.0%Unchanged
Citadel Advisors LLC17,808$3560.00%−100−0.6%Reduced
UBS Group AG6,083$1220.00%−2,706−30.8%Reduced
Clear Street LLC1,893$380.00%−500−20.9%Reduced
Bank of America Corp499$100.00%−400−44.5%Reduced
LMR Partners LLP0$00.00%−1,624,856−100.0%Sold out
HRT Financial LP0$00.00%−11,098−100.0%Sold out
Virtu Financial LLC0$00.00%−12,749−100.0%Sold out